MY ACCOUNT | NEWSLETTER |

Boehringer Ingelheim sponsors the IPVS 2022 Congress


From June 21 to 26, Rio de Janeiro (Brazil) hosted the 26th edition of the Congress of the International Pig Veterinary Society IPVS (International Pig Veterinary Society). Boehringer Ingelheim did not miss an appointment that is considered one of the most important scientific events in the pig industry at an international level.

The company participated as a sponsor in a congress that, once again, brought together specialists from around the world in animal health, biosecurity, welfare, nutrition, and reproduction. In addition, he organized a previous symposium in which he addressed innovation and technology applied to the farm.

Active participation in the scientific program

Boehringer Ingelheim also took an active part in the scientific program, presenting 40 posters and a total of 11 oral communications.

Among them, Víctor Rodríguez, veterinary technical adviser at Boehringer Ingelheim Animal Health Spain, was in charge of giving an oral presentation entitled: "Can the treatment of sows during lactation help in the control of porcine proliferative enteropathy?". In his intervention, he explained how, in a positive multiplier to Lawsonia intracellularis, oral vaccination against Ileitis was able to improve the growth of sows during lactation, obtaining better results than with the use of medication.

Boehringer Ingelheim's participation in this congress demonstrates its interest in accompanying pig veterinarians, contributing to their technical training, and providing comprehensive solutions to the new challenges currently facing the sector.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top